Abstract
MARIJUANA and many of its constituent cannabinoids influence the central nervous system (CNS) in a complex and dose-dependent manner1,2. Although CNS depression and analgesia are well documented effects of the cannabinoids, the mechanisms responsible for these and other cannabinoid-induced effects are not so far known3. The hydrophobic nature of these substances has suggested that cannabinoids resemble anaesthetic agents in their action, that is, they nonspecifically disrupt cellular membranes. Recent evidence, however, has supported a mechanism involving a G protein-coupled receptor found in brain and neural cell lines, and which inhibits adenylate cyclase activity in a dose-dependent, stereoselective and pertussis toxin-sensitive manner4–7. Also, the receptor is more responsive to psychoactive cannabinoids than to non-psychoactive cannabinoids8. Here we report the cloning and expression of a complementary DNA that encodes a G protein-coupled receptor with all of these properties. Its messenger RNA is found in cell lines and regions of the brain that have cannabinoid receptors. These findings suggest that this protein is involved in cannabinoid-induced CNS effects (including alterations in mood and cognition) experienced by users of marijuana.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
£199.00 per year
only £3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hollister, L. E. Pharmac. Rev. 38, 1–20 (1986).
Martin, B. R. Pharmac. Rev. 38, 45–74 (1986).
Dewey, W. L. Pharmac. Rev. 38, 151–178 (1986).
Howlett, A. C. Molec. Pharmacol. 27, 429–436 (1985).
Howlett, A. C. & Fleming, R. M. Molec. Pharmacol. 26, 532–538 (1984).
Howlett, A. C., Qualy, J. M. & Khachatrian, L. L. Molec. Pharmacol. 29, 307–313 (1986).
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S. & Howlett, A. C. Molec. Pharmacol. 34, 605–613 (1988).
Howlett, A. C. Neuropharmacology 26, 507–512 (1987).
Bonner, T. I., Buckley, N. J., Young, A. C. & Brann, M. R. Science 237, 527–532 (1987).
Nirenburg, M. et al. Science 222, 794–799 (1983).
Devane, W. A., Spain, J. W., Coscia, C. J. & Howlett, A. C. J. Neurochem. 46, 1925–1935 (1986).
Herkenham, M. et al. Proc. natn. Acad. Scl. U.S.A. 87, 1932–1936 (1990).
Bidaut-Russell, M., Devane, W. A. & Howlett, A. C. J. Neurochem. 55, 21–26 (1990).
Howlett, A. C., Johnson, M. R., Melvin, L. S. & Milne, G. M. Molec. Pharmacol. 33, 297–302 (1988).
Razdan, R. K. Pharmac. Rev. 38, 75–149 (1986).
Gilman, A. G. Cell 36, 577–579 (1984).
Lawrence, D. K. & Gill, E. W. Molec. Pharmacol. 11, 595–602 (1975).
Hillard, C. J., Harris, R. A. & Bloom, A. S. J. Pharmac. exp. Ther. 232, 579–588 (1985).
Masu, Y. et al. Nature 329, 836–838 (1987).
McFarland, K. C. et al. Science 245, 494–499 (1989).
Loosfelt, H. et al. Science 245, 525–528 (1989).
Young, D., Waitches, G., Birchmeier, C., Fasano, O. & Wigler, M. Cell 45, 711–719 (1986).
Karnik, S. S., Sakmar, T. P., Chen, H.-B. & Khorana, H. G. Proc. natn. Acad. Sci. U.S.A. 85, 8459–8463 (1988).
Okayama, H. & Berg, P. Molec. cell. Biol. 3, 280–289 (1983).
Chomczynski, P. & Sacchi, N. Analyt. Biochem. 162, 156–159 (1987).
Young, W. S. III, Bonner, T. I. & Brann, M. R. Proc. natn. Acad. Sci. U.S.A. 83, 9827–9831 (1986).
Young, W. S. III, Warden, M. & Mezey, E. Neuroendocrinology 46, 439–444 (1987).
Chen, C. & Okayama, H. Molec. cell. Biol. 7, 2745–2752 (1987).
Brooker, G., Harper, J. F., Terasaki, W. L. & Moylan, R. D. Adv. Cyclic Nucleotide Res. 10, 1–33 (1979).
Borst, S. & Conolly, M. Life Sci. 43, 1021–1030 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Matsuda, L., Lolait, S., Brownstein, M. et al. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561–564 (1990). https://doi.org/10.1038/346561a0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/346561a0
This article is cited by
-
Research progress in the management of vascular disease with cannabidiol: a review
Journal of Cardiothoracic Surgery (2024)
-
Cannabinoids induce cell death in leukaemic cells through Parthanatos and PARP-related metabolic disruptions
British Journal of Cancer (2024)
-
Repeated Δ-9-Tetrahydrocannabinol administration dose dependently increases stablished schedule-induced drinking
Psychopharmacology (2024)
-
The State of Synthetic Cannabinoid Medications for the Treatment of Pain
CNS Drugs (2024)
-
Potent dual MAGL/FAAH inhibitor AKU-005 engages endocannabinoids to diminish meningeal nociception implicated in migraine pain
The Journal of Headache and Pain (2023)